{
    "code": "02013163",
    "time": "2015-06-25 10:48:54",
    "許可證字號": "衛署藥輸字第013163號",
    "註銷狀態": "已註銷",
    "註銷日期": "99\/09\/21",
    "註銷理由": "未展延而逾期者",
    "有效日期": "97\/12\/07",
    "發證日期": "73\/12\/07",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00201316303",
    "中文品名": "斷巴金錠",
    "英文品名": "DOPERGIN",
    "適應症": "原發性及繼發性斷乳、乳漏、激乳素引起的停經及不孕症（如果是腦下垂體腫瘤引起、只用在顯微手術之後）肢端肥大症、帕金森症",
    "劑型": "110錠劑",
    "包裝": "瓶裝",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "主成分略述": "LISURIDE HYDROGEN MELEATE",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "1426201100  臺灣拜耳股份有限公司",
    "申請商地址": "台北巿信義區信義路五段7號台北101大樓之53至54樓",
    "主製造廠": {
        "製造廠名稱": "F150157000  SCHERING S.A.",
        "製造廠廠址": "RUE DE TOUFFLERS Z.I. DE ROUBAIX-EST 59390 LYS LEZ LANNOY FRANCE",
        "製造廠公司地址": "",
        "製造廠國別": "FRANCE",
        "製程": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "7600001110",
            "成分名稱": "LISURIDE HYDROGEN MELEATE",
            "含量描述": "",
            "含量": "0.2000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "白色",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "圓扁形",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "圖片",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02013163&Seq=419&Type=10"
        }
    ]
}